Toth Financial Advisory
RYTM icon

Toth Financial Advisory’s Rhythm Pharmaceuticals RYTM Stock Holding History

Toth Financial Advisory’s Portfolio RYTM Stock Details RYTM Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q3 		$743K Hold
7,800
– – 0.07% 156
2026
Q2 		$866K Sell
7,800
-2,200
-22% -$199K 0.08% 150
2026
Q1 		$870K Hold
10,000
– – 0.1% 139
2025
Q4 		$1.07M Hold
10,000
– – 0.12% 131
2025
Q3 		$1.01M Hold
10,000
– – 0.11% 135
2025
Q2 		$632K Buy
+10,000
New +$612K 0.07% 147

Other funds holding RYTM

Assenagon Asset Management
Assenagon Asset Management Senningerberg, Luxembourg $103B AUM 40.17% 1-Year Est. Return
Wedge Capital Management
Wedge Capital Management Charlotte, North Carolina $5.72B AUM 38.26% 1-Year Est. Return
Cannon Financial Strategists
Cannon Financial Strategists Athens, Georgia $885M AUM 13.17% 1-Year Est. Return
Aspiriant LLC
Aspiriant LLC Los Angeles, California $4.08B AUM 12.02% 1-Year Est. Return
Avior Wealth Management
Avior Wealth Management Omaha, Nebraska $3.79B AUM 15.36% 1-Year Est. Return
Abel Hall LLC
Abel Hall LLC Baton Rouge, Louisiana $556M AUM 43.18% 1-Year Est. Return
Fulton Bank
Fulton Bank Lancaster, Pennsylvania $3.29B AUM 13.65% 1-Year Est. Return
Atria Investments
Atria Investments Charlotte, North Carolina $10.3B AUM 19.62% 1-Year Est. Return
Elevation Wealth Partners
Elevation Wealth Partners Santa Rosa, California $356M AUM 17.04% 1-Year Est. Return
Nisa Investment Advisors
Nisa Investment Advisors St. Louis, Missouri $34.7B AUM 25.93% 1-Year Est. Return

Toth Financial Advisory's RYTM Position: Q3 2026 in Review

Toth Financial Advisory held its Rhythm Pharmaceuticals (RYTM) position steady in Q3 2026 at 7,800 shares worth $743K. The position accounts for 0.07% of the portfolio, ranked #156.

Toth Financial Advisory first reported a position in RYTM in Q2 2025 and has held it in 6 quarters since. The position peaked at $1.07M in Q4 2025. 28 funds tracked by Wall St. Rank hold RYTM as of Q3 2026.

  • Toth Financial Advisory held 7,800 shares of Rhythm Pharmaceuticals worth $743K as of Q3 2026.
  • Toth Financial Advisory left its Rhythm Pharmaceuticals share count unchanged in Q3 2026.
  • Rhythm Pharmaceuticals made up 0.07% of Toth Financial Advisory's portfolio in Q3 2026, its #156 holding.
  • Toth Financial Advisory first reported a position in Rhythm Pharmaceuticals in Q2 2025 and has held it in 6 quarters since.
  • Toth Financial Advisory's Rhythm Pharmaceuticals position peaked at $1.07M in Q4 2025.
  • 28 funds tracked by Wall St. Rank held Rhythm Pharmaceuticals as of Q3 2026.

Based on Toth Financial Advisory's 13F filing for Q3 2026, filed 8 Oct 2026.